ERBB2 and breast cancer: Moreover, plasma circulating miRNAs that have been described to be associated with pathological response in Her2+ BC patients (rev in [38]) such as miR-140-3p, miR-195-5p, miR- 373-3p, and let-7a-3p were negative in our samples.